These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37571807)

  • 1. The real-life efficacy of methotrexate in vitiligo: A retrospective study and literature review.
    Speeckaert R; van Geel N
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2267-2269. PubMed ID: 37571807
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of the combination of steroid pulse therapy with methotrexate for vitiligo: A pilot retrospective case series.
    Guyon M; Merhi R; Andreu N; Boniface K; Seneschal J
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2264-2266. PubMed ID: 37561929
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical methotrexate 1% gel for treatment of vitiligo: A case report and review of the literature.
    Abdelmaksoud A; Dave DD; Lotti T; Vestita M
    Dermatol Ther; 2019 Sep; 32(5):e13013. PubMed ID: 31265164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blue light-emitting diodes for the treatment of localized vitiligo: A retrospective study.
    Lodi G; Del Re C; Nisticò SP; Bennardo L; Cannarozzo G; Sannino M
    J Cosmet Dermatol; 2023 Apr; 22(4):1273-1278. PubMed ID: 36575871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate for treatment of vitiligo.
    Abdelmaksoud A
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28796400
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of the outcome measures used in clinical trials for vitiligo.
    Br J Dermatol; 2023 Feb; 188(2):e17. PubMed ID: 36763883
    [No Abstract]   [Full Text] [Related]  

  • 7. Onset of vitiligo in a psoriasis patient on ixekizumab.
    Marasca C; Fornaro L; Martora F; Picone V; Fabbrocini G; Megna M
    Dermatol Ther; 2021 Sep; 34(5):e15102. PubMed ID: 34436817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter to the editor: "Oral mini-pulse therapy in vitiligo: A systematic review".
    Chavez-Alvarez S; Herz-Ruelas M; Raygoza-Cortez AK; Suro-Santos Y; Ocampo-Candiani J; Alvarez-Villalobos NA; Villarreal-Martinez A
    Int J Dermatol; 2022 Jul; 61(7):e246-e247. PubMed ID: 35239974
    [No Abstract]   [Full Text] [Related]  

  • 9. Intralesional methotrexate in the treatment of localized vitiligo: A pilot study.
    Elrewiny EM; Shawky A; Mohamed SFF; Ammar AM; Mansour M; Rageh MA
    Australas J Dermatol; 2023 Aug; 64(3):e207-e211. PubMed ID: 37166107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current landscape of clinical trials for vitiligo: improving outcome standardization and trial diversity.
    Mulligan KM; O'Connell KA; Coleman MS; da Silva A; Reddy M; Kim L; Bazzi N; Afrin A; Dellavalle RP
    Clin Exp Dermatol; 2023 Jul; 48(7):795-797. PubMed ID: 36916518
    [No Abstract]   [Full Text] [Related]  

  • 11. Using methotrexate in the treatment of advanced vitiligo.
    Tavitova A; Valle Y; Lomonosov K
    J Cosmet Dermatol; 2023 Mar; 22(3):1136-1138. PubMed ID: 36409563
    [No Abstract]   [Full Text] [Related]  

  • 12. Case Report: Successful treatment with methotrexate in a 10-year-old boy with co-occurrence of generalized psoriasis and vitiligo.
    Leong PY; Chiu TM; Wei JC; Huo AP
    Front Immunol; 2023; 14():1255909. PubMed ID: 37854600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of Narrow-Band UVB Phototherapy to Ruxolitinib Cream in Patients With Vitiligo.
    Pandya AG; Harris JE; Lebwohl M; Hamzavi IH; Butler K; Kuo FI; Wei S; Rosmarin D
    J Invest Dermatol; 2022 Dec; 142(12):3352-3355.e4. PubMed ID: 35787401
    [No Abstract]   [Full Text] [Related]  

  • 14. A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo.
    Singh H; Kumaran MS; Bains A; Parsad D
    Dermatology; 2015; 231(3):286-90. PubMed ID: 26278124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undesirable repigmentation in vitiligo patient receiving methotrexate therapy for the treatment of psoriasis: treatment or side effect?
    Ugurer E; Altunay IK; Erdem Y; Ozkur E; Tuncel D
    Dermatol Online J; 2022 Jan; 28(1):. PubMed ID: 35499421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrest of progression and duration to achieve it: an important indicator for efficacy of medication aimed at rapidly progressive vitiligo.
    Patra S; Khaitan BK
    Int J Dermatol; 2022 Jul; 61(7):e245-e246. PubMed ID: 35230707
    [No Abstract]   [Full Text] [Related]  

  • 17. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.
    Mosher DB; Parrish JA; Fitzpatrick TB
    Br J Dermatol; 1977 Dec; 97(6):669-79. PubMed ID: 603749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrowband ultraviolet B phototherapy in pediatric vitiligo: A retrospective study.
    Garza-Mayers AC; Paquette GM; Harris JE; Wiss K
    J Am Acad Dermatol; 2023 Jul; 89(1):135-136. PubMed ID: 36796727
    [No Abstract]   [Full Text] [Related]  

  • 19. Polypodium leucotomos as an adjunct to the treatment of vitiligo.
    Searle T; Al-Niaimi F; Ali FR
    J Am Acad Dermatol; 2022 Feb; 86(2):e65. PubMed ID: 34390787
    [No Abstract]   [Full Text] [Related]  

  • 20. Localised hypopigmentation: clarification of a diagnostic conundrum.
    Poon S; Beach RA
    Br J Gen Pract; 2018 Sep; 68(674):444-445. PubMed ID: 30166398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.